Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sia Mbishi"'
Autor:
Heiko Philippin, MD, Einoti Matayan, MMed, Karin M Knoll, MD, Edith Macha, Pharm Tech, Sia Mbishi, BSc, Andrew Makupa, MMed, Cristóvão Matsinhe, MMed, Vasco da Gama, MMed, Mario Monjane, MMed, Awum Joyce Ncheda, MMed, Francisco Alcides Mulobuana, MMed, Elisante Muna, MMed, Nelly Fopoussi, MMed, Gus Gazzard, ProfFRCOphth, Ana Patricia Marques, PhD, Peter Shah, ProfFRCOphth, David Macleod, PhD, William U Makupa, MMed, Matthew J Burton, ProfPhD
Publikováno v:
The Lancet Global Health, Vol 9, Iss 11, Pp e1589-e1599 (2021)
Summary: Background: Glaucoma is a major cause of sight loss worldwide, with the highest regional prevalence and incidence reported in Africa. The most common low-cost treatment used to control glaucoma is long-term timolol eye drops. However, low ad
Externí odkaz:
https://doaj.org/article/cb9b8403ea26444c81800d7f9d9c086e
Autor:
Heiko Philippin, Einoti Naino Matayan, Karin Marianne Knoll, Edith Macha, Sia Mbishi, Andrew Makupa, Cristóvão Daniel Matsinhe, Isac Vasco da Gama, Mário Jorge Monjane, Joyce Awum Ncheda, Francisco Alcides Francisco Mulobuana, Elisante Muna, Nelly Fopoussi Guylene, Gus Gazzard, Ana Patricia Marques, Peter Shah, David Macleod, William Makupa, Matthew J Burton
Publikováno v:
British Journal of Ophthalmology. :bjophthalmol-2022
BackgroundGlaucoma staging is critical for treatment planning but has rarely been tested in severe/end-stage disease. We compared the performance of the Disc Damage Likelihood Scale (DDLS) and cup:disc ratio (CDR) using a functional glaucoma staging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feef50e4532eec8bc870f4a2b3b3587e
https://doi.org/10.1136/bjo-2022-321643
https://doi.org/10.1136/bjo-2022-321643
Autor:
Francisco Alcides Mulobuana, Edith Macha, Cristóvão Matsinhe, Sia Mbishi, Karin M Knoll, Gus Gazzard, Einoti Matayan, Vasco da Gama, David Macleod, Matthew J. Burton, Awum Joyce Ncheda, Elisante Muna, Ana Patrícia Marques, Heiko Philippin, Andrew Makupa, William Makupa, Peter Shah, Nelly Fopoussi, Mário J. Monjane
Publikováno v:
The Lancet Global Health, Vol 9, Iss 11, Pp e1589-e1599 (2021)
The Lancet. Global Health
The Lancet. Global Health
Summary: Background: Glaucoma is a major cause of sight loss worldwide, with the highest regional prevalence and incidence reported in Africa. The most common low-cost treatment used to control glaucoma is long-term timolol eye drops. However, low ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5a1845f97f01947b270a873665b427b
https://researchonline.lshtm.ac.uk/id/eprint/4663281/7/Philippin_etal_2021_Selective-laser-trabeculoplasty-versus.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4663281/7/Philippin_etal_2021_Selective-laser-trabeculoplasty-versus.pdf
